State KS
Clinical Trials in Kansas
Kansas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Kansas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 141 actively recruiting studies with Kansas sites out of 141 registered in total. The busiest research areas in Kansas are Breast Cancer, Cystic Fibrosis, Prostate Cancer. Leading sponsors running trials in the state include National Cancer Institute (NCI), University of Kansas Medical Center, AstraZeneca. By stage, Kansas trials break down as Phase 1 (22), Phase 2 (34), Phase 3 (46), Phase 4 (2).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Kansas
Frequently Asked Questions — Clinical Trials in Kansas
How many clinical trials are currently recruiting in Kansas?
ClinicalMetric currently tracks 141 actively recruiting clinical trials with at least one location in Kansas. The total number of registered studies—including active but not currently enrolling trials—is 141. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Kansas?
Kansas hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Cystic Fibrosis, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Kansas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Kansas?
To join a clinical trial in Kansas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Kansas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Kansas
NCT05711394 Phase 3
Recruiting
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atog...
Condition
Episodic Migraine
Enrollment
450 pts
Location
United States, Belgium, Canada
Sponsor
AbbVie
NCT04994756 N/A
Recruiting
Stroke Thrombectomy and Aneurysm Registry
Condition
Stroke
Enrollment
40,000 pts
Location
United States, Canada, Germany
Sponsor
Medical University of South Ca
NCT06787612 Phase 2
Recruiting
Investigation of Ubamatamab Combination Therapy in Adult Participants With Plati...
Condition
Ovarian Cancer
Enrollment
220 pts
Location
United States, Canada, South Korea
Sponsor
Regeneron Pharmaceuticals
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05147792 N/A
Recruiting
The CONFORM Pivotal Trial
Condition
Atrial Fibrillation
Enrollment
1,600 pts
Location
United States, Czechia, France
Sponsor
Conformal Medical, Inc
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
NCT07661056 Phase 3
Recruiting
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Dise...
Condition
Graves Disease
Enrollment
300 pts
Location
United States
Sponsor
Biohaven Therapeutics Ltd.
NCT06939257 N/A
Recruiting
Pain Outcomes Associated With Exogenous Hormone Therapy in Adults
Condition
Pain
Enrollment
200 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT06872684 N/A
Recruiting
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Sur...
Condition
Aneurysm
Enrollment
183 pts
Location
United States
Sponsor
Stryker Neurovascular
NCT04486352 Phase 1, Phase 2
Recruiting
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial...
Condition
Endometrial Cancer
Enrollment
148 pts
Location
United States
Sponsor
Alliance Foundation Trials, LL
NCT07222917 Phase 2
Recruiting
A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Ba...
Condition
Chronic Kidney Disease and Hypertension
Enrollment
218 pts
Location
United States, Argentina, Bulgaria
Sponsor
AstraZeneca
NCT06337318 Phase 3
Recruiting
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor ...
Condition
Classic Follicular Lymphoma
Enrollment
600 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06524882 Phase 3
Recruiting
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
Condition
Amblyopia
Enrollment
252 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
NCT05564390 Phase 2
Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatmen...
Condition
Acute Myeloid Leukemia
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT05530408 N/A
Recruiting
Quantitative Pulmonary Imaging Registry & Biorepository
Condition
Pulmonary Disease
Enrollment
100 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT00291096 N/A
Recruiting
High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Bre...
Condition
Breast Cancer
Enrollment
3,000 pts
Location
United States
Sponsor
Carol Fabian, MD
NCT07115940 N/A
Recruiting
Medical Management With Endovascular Thrombectomy Versus Medical Management Alon...
Condition
Acute Ischemic Stroke
Enrollment
408 pts
Location
United States
Sponsor
Amrou Sarraj
NCT04493970 N/A
Recruiting
HS Students Mandatory Universal Student Instruction in CPR Appraised Learning- I...
Condition
Sudden Cardiac Arrest
Enrollment
5,000 pts
Location
United States
Sponsor
Kansas City Heart Rhythm Resea
NCT06627673 N/A
Recruiting
MultiCenter IDE Study of the PEEK-OPTIMA™ Femoral Component vs a CoCr Alloy TKA ...
Condition
Knee Osteoarthritis
Enrollment
200 pts
Location
United States
Sponsor
Maxx Orthopedics Inc
NCT07093580 Phase 1
Recruiting
Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Condition
Healthy Participants
Enrollment
98 pts
Location
United States
Sponsor
Shionogi
NCT06107959 N/A
Recruiting
Changes in Resting Metabolic Rate Following Orthopedic Surgery
Condition
Metabolism; Disorder, Postprocedural
Enrollment
100 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT04467723 Phase 1, Phase 2
Recruiting
Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC
Condition
NSCLC Stage IV
Enrollment
25 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT07225946 Phase 3
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metas...
Condition
Prostatic Neoplasms, Castration-Resistant
Enrollment
800 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
NCT06915753 Phase 1
Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellula...
Condition
Metastatic Hepatocellular Carcinoma
Enrollment
100 pts
Location
United States, Canada, South Korea
Sponsor
Tyra Biosciences, Inc
NCT01810913 Phase 2, Phase 3
Recruiting
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizum...
Condition
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma
Enrollment
613 pts
Location
United States, Canada, Hong Kong
Sponsor
National Cancer Institute (NCI
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology